Concepedia

Alok C. Bharti

AC

Statistics

Publications

74

Citations

8.2K

H-Index

41

Active since

2000

Affiliations

Institute of Cytology and Preventive Oncology(Current)

University of Delhi

Ambedkar University Delhi

The University of Texas MD Anderson Cancer Center

Indian Council of Medical Research

Alok C. Bharti is an author at Institute of Cytology and Preventive Oncology specializing in medicine, oncology, and molecular oncology.

Publications per year

2000–2023

74

Publications

74

Anticancer potential of curcumin: preclinical and clinical studies.

Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti · PubMed · 2003 · 2.6K citations

Medicine, Oncology, Pharmacology +15

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

Alok C. Bharti, Nicholas J. Donato, Sujay Singh et al. · Blood · 2003 · 683 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

Alok C. Bharti, Nicholas J. Donato, Bharat B. Aggarwal · The Journal of Immunology · 2003 · 504 citations · Full text

Medicine, Immunology, Pharmacology +13

Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

Alok C. Bharti, Shishir Shishodia, James M. Reuben et al. · Blood · 2003 · 321 citations · Full text

Life Sciences, Cell Biology, Hematology +12

Curcumin (Diferuloylmethane) Inhibits Receptor Activator of NF-κB Ligand-Induced NF-κB Activation in Osteoclast Precursors and Suppresses Osteoclastogenesis

Alok C. Bharti, Yasunari Takada, Bharat B. Aggarwal · The Journal of Immunology · 2004 · 267 citations

Life Sciences, Pathobiology, Cell Signaling +16

1–5 of 74